$TENX
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Christopher T. Giordano
CEO
4
Employees
$1.98
Current Price
$59.08M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 1 | 4 | $2,985,909.78 | 1,670,333 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 1 | 7 | $4,800,057.27 | 2,696,200 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 1 | 7 | $4,800,057.27 | 2,696,200 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 1 | 7 | $4,800,057.27 | 2,696,200 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | ADAR1 Capital Management, LLC 10% Owner | Purchase | 900,000 | $1.78 | $1,604,160.00 | View Details |
| Sep 1, 2026 | ADAR1 Capital Management, LLC 10% Owner | Purchase | 179,058 | $1.80 | $321,570.26 | View Details |
| Aug 31, 2026 | ADAR1 Capital Management, LLC 10% Owner | Purchase | 403,571 | $1.79 | $722,593.88 | View Details |
| Sep 2, 2026 | ADAR1 Capital Management, LLC 10% Owner | Purchase | 187,704 | $1.80 | $337,585.64 | View Details |
| Aug 21, 2026 | ADAR1 Capital Management, LLC 10% Owner | Purchase | 716,369 | $1.77 | $1,266,253.84 | View Details |
| Aug 24, 2026 | ADAR1 Capital Management, LLC 10% Owner | Purchase | 107,374 | $1.75 | $188,355.47 | View Details |
| Aug 20, 2026 | ADAR1 Capital Management, LLC 10% Owner | Purchase | 202,124 | $1.78 | $359,538.17 | View Details |
13 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: